Advanced Catheter Therapy Inc, based in Chattanooga, TN, is a leading medical device company that specializes in the development and commercialization of innovative catheter technologies. Their flagship product, the Pressana Occlusion Perfusion Catheter (OPC), is a next-generation universal delivery device designed for the targeted delivery of various therapeutic agents for the treatment of different disease states. With its demonstrated safety and efficacy, the Pressana OPC offers substantial procedural control and is cost-effective, making it a valuable tool in preventing lower limb amputations and addressing peripheral arterial disease.
Developed by Advanced Catheter Therapies, the Pressana OPC has received FDA clearance for below-the-knee use and is the only liquid drug delivery technology actively marketed for this purpose. It enables direct endovascular delivery and infusion of physician-prescribed therapeutic and diagnostic agents, providing enhanced distribution and reduced agent volume. With multiple FDA clearances and patents, Advanced Catheter Therapies continues to lead the way in the development of innovative catheter technologies that improve patient outcomes and revolutionize the field of interventional medicine.
Generated from the website